Cliff Asness's RXRX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 244,391 shares of Recursion Pharmaceuticals, Inc. (RXRX) worth $750,281, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 7 quarters.
Based on 13F filings, Cliff Asness has maintained this position in RXRX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 244,391 shares. Largest reduction occurred in Q2 2025, reducing 154,291 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Recursion Pharmaceuticals (RXRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Recursion Pharmaceuticals (RXRX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +244,391 | New Buy | 244,391 | $3.07 |
| Q4 2025 | -14,910 | Sold Out | 0 | $0.00 |
| Q3 2025 | +1,010 | Add 7.27% | 14,910 | $4.88 |
| Q2 2025 | -154,291 | Reduce 91.74% | 13,900 | $5.06 |
| Q1 2025 | +168,191 | New Buy | 168,191 | $5.29 |
| Q2 2024 | -14,985 | Sold Out | 0 | $0.00 |
| Q1 2024 | +14,985 | New Buy | 14,985 | $9.97 |
Cliff Asness's Recursion Pharmaceuticals Investment FAQs
Cliff Asness first purchased Recursion Pharmaceuticals, Inc. (RXRX) in Q1 2024, acquiring 14,985 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Recursion Pharmaceuticals, Inc. (RXRX) for 7 quarters since Q1 2024.
Cliff Asness's largest addition to Recursion Pharmaceuticals, Inc. (RXRX) was in Q1 2026, adding 244,391 shares worth $750,281.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 244,391 shares of Recursion Pharmaceuticals, Inc. (RXRX), valued at approximately $750,281.
As of the Q1 2026 filing, Recursion Pharmaceuticals, Inc. (RXRX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Recursion Pharmaceuticals, Inc. (RXRX) was 244,391 shares, as reported at the end of Q1 2026.